Rubin DT - Search Results

1

Long-term Efficacy of Vedolizumab for Ulcerative Colitis.

Loftus EV Jr, Colombel JF, Feagan BG, Vermeire S, Sandborn WJ, Sands BE, Danese S, D'Haens GR, Kaser A, Panaccione R, Rubin DT, Shafran I, McAuliffe M, Kaviya A, Sankoh S, Mody R, Abhyankar B, Smyth M. Loftus EV Jr, et al. Among authors: rubin dt. J Crohns Colitis. 2017 Apr 1;11(4):400-411. doi: 10.1093/ecco-jcc/jjw177. J Crohns Colitis. 2017. PMID: 27683800 Clinical Trial.

2

Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.

Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP, Pollack PF, Chao J, Mulani P. Loftus EV, et al. Among authors: rubin dt. Am J Gastroenterol. 2008 Dec;103(12):3132-41. doi: 10.1111/j.1572-0241.2008.02175.x. Epub 2008 Oct 3. Am J Gastroenterol. 2008. PMID: 18853973 Clinical Trial.

3

Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey.

Rubin DT, Siegel CA, Kane SV, Binion DG, Panaccione R, Dubinsky MC, Loftus EV, Hopper J. Rubin DT, et al. Inflamm Bowel Dis. 2009 Apr;15(4):581-8. doi: 10.1002/ibd.20793. Inflamm Bowel Dis. 2009. PMID: 19067414

4

Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.

Afif W, Leighton JA, Hanauer SB, Loftus EV Jr, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA, Sandborn WJ. Afif W, et al. Among authors: rubin dt. Inflamm Bowel Dis. 2009 Sep;15(9):1302-7. doi: 10.1002/ibd.20924. Inflamm Bowel Dis. 2009. PMID: 19408340 Clinical Trial.

5

The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey.

Rubin DT, Dubinsky MC, Panaccione R, Siegel CA, Binion DG, Kane SV, Hopper J. Rubin DT, et al. Dig Dis Sci. 2010 Apr;55(4):1044-52. doi: 10.1007/s10620-009-0953-7. Epub 2009 Sep 4. Dig Dis Sci. 2010. PMID: 20155319

6

When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations.

Siegel CA, Schwartz LM, Woloshin S, Cole EB, Rubin DT, Vay T, Baars J, Sands BE. Siegel CA, et al. Among authors: rubin dt. Inflamm Bowel Dis. 2010 Oct;16(10):1658-62. doi: 10.1002/ibd.21233. Inflamm Bowel Dis. 2010. PMID: 20186940 Free PMC article.

7

Clinical scenarios in IBD: optimizing the use of conventional and biologic agents.

Hanauer SB, Kornbluth AA, Messick J, Rubin DT, Sandborn WJ, Sands BE. Hanauer SB, et al. Among authors: rubin dt. Inflamm Bowel Dis. 2010 Dec;16 Suppl 1:S1-11. doi: 10.1002/ibd.21529. Inflamm Bowel Dis. 2010. PMID: 21104734 Review. No abstract available.

8

A practical, evidence-based guide to the use of adalimumab in Crohn's disease.

Rubin DT, Panaccione R, Chao J, Robinson AM. Rubin DT, et al. Curr Med Res Opin. 2011 Sep;27(9):1803-13. doi: 10.1185/03007995.2011.604672. Epub 2011 Aug 2. Curr Med Res Opin. 2011. PMID: 21809894 Review.

9

Assessment of variables associated with smoking cessation in Crohn's disease.

Leung Y, Kaplan GG, Rioux KP, Hubbard J, Kamhawi S, Stasiak L, Cohen RD, Devlin SM, Panaccione R, Hanauer SB, Rubin DT. Leung Y, et al. Among authors: rubin dt. Dig Dis Sci. 2012 Apr;57(4):1026-32. doi: 10.1007/s10620-012-2038-2. Epub 2012 Feb 7. Dig Dis Sci. 2012. PMID: 22311366

10

Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis.

Calabrese E, Yanai H, Shuster D, Rubin DT, Hanauer SB. Calabrese E, et al. Among authors: rubin dt. J Crohns Colitis. 2012 Aug;6(7):756-62. doi: 10.1016/j.crohns.2011.12.010. Epub 2012 Jan 15. J Crohns Colitis. 2012. PMID: 22398093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page